12 About this guidance

Why is this guidance being produced?

The Department of Health (DH) asked the National Institute for Health and Care Excellence (NICE) to produce this guidance.

The guidance should be implemented alongside other guidance and regulations (for more details see Implementation and Related NICE guidance respectively).

How was this guidance developed?

The guidance is based on the best available evidence. It was developed by the Public Health Interventions Advisory Committee (PHIAC).

Members of PHIAC are listed in Public Health Interventions Committee and the NICE project team.

For information on how NICE public health guidance is developed, see the NICE public health guidance process and methods guides.

What evidence is the guidance based on?

The evidence that PHIAC considered included:

  • Evidence review:

    • Review 1: 'Body mass index and waist circumference thresholds for intervening to prevent ill health among black, Asian and other minority ethnic groups in the UK' was carried out by Bazian Ltd. The principal authors were: Sarah Caton, Rob Cook and Alicia White.

  • Expert reports:

    • Expert report 1: 'What are the cut-off points for body mass index (BMI) and waist circumference among adults from black, Asian and other minority ethnic groups living in the UK that are "risk equivalent" to the current thresholds set for white European populations? Analyses from the ADDITION-Leicester Study'. This was carried out by Danielle Morris and Kamlesh Khunti (Diabetes Research Unit), Laura Gray and Melanie Davies (Department of Health Sciences) at the University of Leicester; and Naveed Sattar at University of Glasgow Institute of Cardiovascular and Medical Sciences.

    • Expert report 2:'Ethnicity-specific obesity cut-off points in the development of incident type 2 diabetes – a prospective study (SABRE) including three ethnic groups in the United Kingdom'. This was carried out by Dr Nita Forouhi, Medical Research Council Epidemiology Unit, Cambridge and Professor Naveed Sattar, Cardiovascular Research Centre, University of Glasgow.

In some cases the evidence was insufficient and PHIAC has made recommendations for future research.

Status of this guidance

The draft guidance was released for consultation in December 2012. At its meeting in March 2013, PHIAC amended the guidance in light of comments from stakeholders and experts and the expert testimony. The guidance was signed off by the NICE Guidance Executive in June 2013.

The guidance is available on NICE's website. The recommendations will also be available in a pathway for professionals whose remit includes public health and for interested members of the public.

Implementation

NICE guidance can help:

NICE has developed tools to help organisations put this guidance into practice.

Updating the recommendations

This guidance will be reviewed 3 years after publication to determine whether all or part of it should be updated. Information on the progress of any update will be posted on the NICE website.

Your responsibility

This guidance represents the views of the Institute and was arrived at after careful consideration of the evidence available. Those working in the NHS, local authorities, the wider public, voluntary and community sectors and the private sector should take it into account when carrying out their professional, managerial or voluntary duties.

Implementation of this guidance is the responsibility of local commissioners and/or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way which would be inconsistent with compliance with those duties.

Copyright

© National Institute for Health and Care Excellence 2013. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.

Contact NICE

National Institute for Health and Clinical Excellence
Level 1A, City Tower, Piccadilly Plaza, Manchester M1 4BT

www.nice.org.uk

nice@nice.org.uk

0845 033 7780

ISBN: 978-1-4731-0186-9

  • National Institute for Health and Care Excellence (NICE)